Literature DB >> 20935208

Differential requirement of histone acetylase and deacetylase activities for IRF5-mediated proinflammatory cytokine expression.

Di Feng1, Niquiche Sangster-Guity, Rivka Stone, Justyna Korczeniewska, Margo E Mancl, Patricia Fitzgerald-Bocarsly, Betsy J Barnes.   

Abstract

Recent evidence indicates a new role for histone deacetylases (HDACs) in the activation of genes governing the host immune response. Virus, along with other pathogenic stimuli, triggers an antiviral defense mechanism through the induction of IFN, IFN-stimulated genes, and other proinflammatory cytokines. Many of these genes have been shown to be regulated by transcription factors of the IFN regulatory factor (IRF) family. Recent studies from IRF5 knockout mice have confirmed a critical role for IRF5 in virus-induced type I IFN expression and proinflammatory cytokines IL-6, IL-12, and TNF-α; yet, little is known of the molecular mechanism of IRF5-mediated proinflammatory cytokine expression. In this study, we show that both HDACs and histone acetyltransferases (HATs) associate with IRF5, leading to alterations in its transactivation ability. Using the HDAC inhibitor trichostatin A, we demonstrate that ISRE, IFNA, and IL6 promoters require HDAC activity for transactivation and transcription, whereas TNFα does not. Mapping the interaction of corepressor proteins (HDAC1, silencing mediator of retinoid and thyroid receptor/nuclear corepressor of retinoid receptor, and Sin3a) and HATs to IRF5 revealed distinct differences, including the dependence of IRF5 phosphorylation on HAT association resulting in IRF5 acetylation. Data presented in this study support a mechanism whereby virus triggers the dynamic conversion of an IRF5-mediated silencing complex to that of an activating complex on promoters of target genes. These data provide the first evidence, to our knowledge, of a tightly controlled transcriptional mechanism whereby IRF5 regulates proinflammatory cytokine expression in conjunction with HATs and HDACs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20935208      PMCID: PMC3233222          DOI: 10.4049/jimmunol.1000482

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  74 in total

1.  Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus.

Authors:  Di Feng; Rivka C Stone; Maija-Leena Eloranta; Niquiche Sangster-Guity; Gunnel Nordmark; Snaevar Sigurdsson; Chuan Wang; Gunnar Alm; Ann-Christine Syvänen; Lars Rönnblom; Betsy J Barnes
Journal:  Arthritis Rheum       Date:  2010-02

Review 2.  Recent insights into the genetic basis of systemic lupus erythematosus.

Authors:  K L Moser; J A Kelly; C J Lessard; J B Harley
Journal:  Genes Immun       Date:  2009-05-14       Impact factor: 2.676

Review 3.  Regulation of immunity and oncogenesis by the IRF transcription factor family.

Authors:  David Savitsky; Tomohiko Tamura; Hideyuki Yanai; Tadatsugu Taniguchi
Journal:  Cancer Immunol Immunother       Date:  2010-01-05       Impact factor: 6.968

4.  Functional regulation of MyD88-activated interferon regulatory factor 5 by K63-linked polyubiquitination.

Authors:  Mumtaz Yaseen Balkhi; Katherine A Fitzgerald; Paula M Pitha
Journal:  Mol Cell Biol       Date:  2008-09-29       Impact factor: 4.272

5.  Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo.

Authors:  Silvia N Kariuki; Kyriakos A Kirou; Emma J MacDermott; Lilliana Barillas-Arias; Mary K Crow; Timothy B Niewold
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

6.  Differential regulation of human interferon A gene expression by interferon regulatory factors 3 and 7.

Authors:  Pierre Génin; Rongtuan Lin; John Hiscott; Ahmet Civas
Journal:  Mol Cell Biol       Date:  2009-04-06       Impact factor: 4.272

7.  Insights into interferon regulatory factor activation from the crystal structure of dimeric IRF5.

Authors:  Weijun Chen; Suvana S Lam; Hema Srinath; Zhaozhao Jiang; John J Correia; Celia A Schiffer; Katherine A Fitzgerald; Kai Lin; William E Royer
Journal:  Nat Struct Mol Biol       Date:  2008-10-05       Impact factor: 15.369

Review 8.  Toll-like receptors in systemic lupus erythematosus; prospects for therapeutic intervention.

Authors:  Wan-Uk Kim; Antoine Sreih; Richard Bucala
Journal:  Autoimmun Rev       Date:  2008-08-21       Impact factor: 9.754

9.  IRF-5 is a mediator of the death receptor-induced apoptotic signaling pathway.

Authors:  Guodong Hu; Betsy J Barnes
Journal:  J Biol Chem       Date:  2008-11-20       Impact factor: 5.157

10.  TLR7-dependent and FcgammaR-independent production of type I interferon in experimental mouse lupus.

Authors:  Pui Y Lee; Yutaro Kumagai; Yi Li; Osamu Takeuchi; Hideo Yoshida; Jason Weinstein; Erinn S Kellner; Dina Nacionales; Tolga Barker; Kindra Kelly-Scumpia; Nico van Rooijen; Himanshu Kumar; Taro Kawai; Minoru Satoh; Shizuo Akira; Westley H Reeves
Journal:  J Exp Med       Date:  2008-12-01       Impact factor: 14.307

View more
  40 in total

1.  PKC alpha regulates Sendai virus-mediated interferon induction through HDAC6 and β-catenin.

Authors:  Jianzhong Zhu; Carolyn B Coyne; Saumendra N Sarkar
Journal:  EMBO J       Date:  2011-09-27       Impact factor: 11.598

Review 2.  The Opportunity of Precision Medicine for Breast Cancer With Context-Sensitive Tumor Suppressor Maspin.

Authors:  Margarida M Bernardo; Sijana H Dzinic; Maria J Matta; Ivory Dean; Lina Saker; Shijie Sheng
Journal:  J Cell Biochem       Date:  2017-03-21       Impact factor: 4.429

Review 3.  Understanding Human Autoimmunity and Autoinflammation Through Transcriptomics.

Authors:  Romain Banchereau; Alma-Martina Cepika; Jacques Banchereau; Virginia Pascual
Journal:  Annu Rev Immunol       Date:  2017-01-30       Impact factor: 28.527

4.  Mitogen-activated protein kinase-mediated licensing of interferon regulatory factor 3/7 reinforces the cell response to virus.

Authors:  Sonja Schmid; David Sachs; Benjamin R tenOever
Journal:  J Biol Chem       Date:  2013-11-25       Impact factor: 5.157

Review 5.  Epigenetic Mechanisms in Monocytes/Macrophages Regulate Inflammation in Cardiometabolic and Vascular Disease.

Authors:  Frank M Davis; Katherine A Gallagher
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-04       Impact factor: 8.311

Review 6.  The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases.

Authors:  Xiao-Jing Zhang; Ding-Sheng Jiang; Hongliang Li
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

7.  Association of interferon regulatory factor 5 (IRF5) gene polymorphisms with juvenile idiopathic arthritis.

Authors:  Samira Esmaeili Reykande; Arezou Rezaei; Maryam Sadr; Mahsima Shabani; Farnaz Najmi Varzaneh; Vahid Ziaee; Nima Rezaei
Journal:  Clin Rheumatol       Date:  2018-02-08       Impact factor: 2.980

8.  Histone deacetylase sirtuin 1 deacetylates IRF1 protein and programs dendritic cells to control Th17 protein differentiation during autoimmune inflammation.

Authors:  Heeyoung Yang; Sang-Myeong Lee; Beixue Gao; Jinping Zhang; Deyu Fang
Journal:  J Biol Chem       Date:  2013-11-08       Impact factor: 5.157

9.  IRF5 regulates unique subset of genes in dendritic cells during West Nile virus infection.

Authors:  Kwan T Chow; Connor Driscoll; Yueh-Ming Loo; Megan Knoll; Michael Gale
Journal:  J Leukoc Biol       Date:  2018-11-20       Impact factor: 4.962

10.  Interferon regulatory factor 5-dependent immune responses in the draining lymph node protect against West Nile virus infection.

Authors:  Larissa B Thackray; Bimmi Shrestha; Justin M Richner; Jonathan J Miner; Amelia K Pinto; Helen M Lazear; Michael Gale; Michael S Diamond
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.